Benchmarking Economics Pharmaceutical 
Musings on Markets
OCTOBER 28, 2024
The motivations for the practice vary, and the payoff from CVC is debatable, but it is undeniable that CVC is growing as a segment of venture capital, and that it is not only affecting the pricing of the young companies that are targeted, but also altering the economics of venture capital, in the aggregate.
Global Finance
OCTOBER 10, 2024
Much more is needed: The Central Bank of the Republic of Argentina (BCRA) still lacks independence from the government, and the ongoing economic and financial changes are part of a radical deregulation and modernization agenda that will take time to implement. Still, the rate of GDP expansion is petering out, from 17% in 2021 to 14.4%
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CFO News Room
FEBRUARY 2, 2022
So, you have the headquarters of a big pharmaceutical company, and they — they’re looking to raise some cash, maybe not a pharmaceutical company, but some other business. economics, correct. RITHOLTZ: Oh, not the control, just the economics. capital problem helps improve our economic sharing …. Is that right?
Barry Ritholtz
DECEMBER 12, 2023
He has absolutely crushed his benchmark over that period. He’s crushed the Russell 2000, whatever benchmark you want to talk about. You’re 34th, you’re retiring after 34 years and you trounce what’s really the more appropriate benchmark, I would assume the Russell 2000. a year since 1989. Much better.
Barry Ritholtz
MARCH 14, 2023
You get a BA in Economics from Hamilton College. So what we did was we figured out the economic rationale, the macroeconomic influences about why growth and value work at any point in time. BERNSTEIN: I was a maintenance guy in a pharmaceutical plant. I found this conversation to be fascinating, and I think you will also.
Expert insights. Personalized for you.
66 
Let's personalize your content